Jihad Aljabban

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Top Venues

Case reports in hepatology

Clinical liver disease

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Mark Matusak, Jihad Aljabban, Mark Wirtz, Rashmi Agni, Erin Spengler
Cholestasis Linked to Bodybuilding Supplements: Exploring the Risks of Contamination. Case reports in hepatology 2024 (2024)
Mark Matusak, Jihad Aljabban, Mark Wirtz, Rashmi Agni, Erin Spengler
Cholestasis Linked to Bodybuilding Supplements: Exploring the Risks of Contamination. Case reports in hepatology 2024 (2024)
Jihad Aljabban, William J Burlingham, Michael R Lucey
The potential role of infusions of T regulatory cells in inducing and maintaining liver allograft tolerance. Clinical liver disease 22 (4) (2023)
David Z Allen, Jihad Aljabban, Dustin Silverman, Sean McDermott, Ross A Wanner, Michael Rohr, Dexter Hadley, Maryam Panahiazar
Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis. PloS one 16 (10) (2021)
Laith K Hasan, Jihad Aljabban, Michael Rohr, Mohamed Mukhtar, Nikhil Adapa, Rahaf Salim, Nabeal Aljabban, Saad Syed, Sharjeel Syed, Maryam Panahiazar, Dexter Hadley, Wael Jarjour
Metaanalysis Reveals Genetic Correlates of Osteoporosis Pathogenesis. The Journal of rheumatology 48 (6) (2020)